Insider Transactions Reported by 14 Insiders of Aptose Biosciences Inc.

Symbol
APTOF on OTC
Location
Toronto

There are no Buy or Sell transactions made by insiders since 18 Mar 2025

Aptose Biosciences Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Donald R. Wilson Jr. 10%+ Owner $12,885,141 03 Aug 2021
William G. Rice Chair, President & CEO, Director $122,650 25 Nov 2024
Hanmi Pharmaceutical Co., Ltd. 10%+ Owner $101,742 18 Mar 2025
Bernd R. Seizinger Director $24,633 05 Feb 2024
Rafael Bejar Sr VP & Chief Medical Officer 05 Feb 2024
Caroline M. Loewy Former Director 31 May 2022
Philippe Ledru Former Officer 23 Feb 2024
Carol Gail Ashe Director 05 Feb 2024
Fletcher Payne Sr VP and CFO 05 Feb 2024
Mark D. Vincent Director 05 Feb 2024
Jotin Marango Senior VP, CFO, and CBO 18 Jan 2022
Warren Whitehead Director 05 Feb 2024
Denis R. Burger Director 05 Feb 2024
Erich Platzer Director 05 Feb 2024

Recent Insider Transactions by Companies or Individuals for Aptose Biosciences Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Hanmi Pharmaceutical Co., Ltd. APTOF Common Shares 0 508,710 18 Mar 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.